Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/1998
06/17/1998CN1185209A Assaying protein fragments in body fluids
06/17/1998CN1185176A DNA encoding human paplilloma virus type 18
06/17/1998CN1185161A (1--3)-beta-d-glucan-binding protein, antidody that recognizes the prolein, and use of the protein and antibody
06/17/1998CN1184817A Method for preparing active immunoglobulin used as oral liquor
06/16/1998US5767372 Chimeric gene comprising dna encoding insecticidal protein fragment, having promoter region and polyadenylation signal allowing dna to be expressed in plant cell
06/16/1998US5767285 Linkers useful for the synthesis of conjugates of methyltrithio antitumor agents
06/16/1998US5767260 A nucleic acid coding for two epitope-containing polypeptide joined by a peptide linker and attached to phospholipase a activating protein or tumor necrosis factor; antiinflammatory agents
06/16/1998US5767249 Monoclonal antibodies against type I phospholipase A2 as a diagnostic and anti-inflammatory therapeutic agent
06/16/1998US5767248 Alzheimers
06/16/1998US5767247 Anti-annexin-V monoclonal antibodies, and preparation and use thereof
06/16/1998US5767246 Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
06/16/1998US5767243 A complex of human afamin and apolipoprotein a1; a monoclonal antibody specific for human afamin
06/16/1998US5767241 Soluble form of GMP-140
06/16/1998US5767240 Activity-dependent neurotrophic factor
06/16/1998US5767089 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
06/16/1998US5767074 Comprises a soluble c-kit ligand protein and one or more hematopoietic factors selected from interleukins, granulocyte-macrophage-colony stimulating factor, granulocyte-colonyl stimulating factor or erythropoietin
06/16/1998US5767067 Follicle stimulating hormone and pharmaceutical compositions containing same
06/16/1998US5767065 Use of interleukin-4 receptors to inhibit biological responses mediated by interleukin-4
06/16/1998US5767063 Human IL-8 receptor and antibodies thereto
06/16/1998US5766947 Useful in the diagnosis and therapy of a variety of immune-related diseases
06/16/1998US5766946 Monoclonal antibodies to glycoprotein P
06/16/1998US5766943 DNA sequences for soluble form of CD23
06/16/1998US5766923 Isolated nucleic acid encoding ligands for FGFR
06/16/1998US5766920 Therapy for cancer, infections, aids and immune deficiency diseases
06/16/1998US5766917 Method for identifying and producing a protease capable of cleaving the TNF receptor
06/16/1998US5766905 Cytoplasmic bacteriophage display system
06/16/1998US5766902 Transfection process
06/16/1998US5766886 Modified antibody variable domains
06/16/1998US5766880 Lung cancer
06/16/1998US5766867 Non-A, non-B hepatitis related nucleic acids, proteins, peptides, antigens, and antibodies
06/16/1998US5766866 Lymphocyte chemoattractant factor and uses thereof
06/16/1998US5766863 Kinase receptor activation assay
06/16/1998US5766856 Diagnostic method for evaluating advanced glycosylation endproducts using MAC-2 receptor
06/16/1998US5766850 Human β2 integrin α subunit
06/16/1998US5766848 Methods for identifying compounds which specifically bind a human betaine/GABA transporter
06/16/1998US5766846 Methods of screening for compounds which inhibit soluble β-amyloid peptide production
06/16/1998US5766845 Immunoreactive polypeptide compositions
06/16/1998US5766844 Human T-cell line infected with HIV-2 which secretes functionally intact HIV-2 GP160.
06/16/1998US5766838 Manual quantitating the number of leukocyte binding tissue cell over a defind are of tissue sample section
06/16/1998US5766609 Administering to the animal to reduce protease activity of fleas feeding on said animal; antifertility agents; veterinary medicine
06/16/1998US5766606 Genetic manipulation of gene encoding a group b streptococcus surface protein so that it is no longer able to bind to human iga
06/16/1998US5766593 Anti-inflammatory CD14 peptides
06/16/1998US5766591 Methods and compositions useful for inhibition of angiogenesis
06/16/1998US5766590 Therapeutic methods and pharmaceutical compositions
06/16/1998US5766588 Tumor immunotherapy using anti-idiotypic antibodies
06/16/1998US5766581 Increasing platelet number with polypeptide molecules attached to polyethylene glycol
06/16/1998US5766570 Lymphocyte activation antigens and antibodies thereto
06/11/1998WO1998025145A1 Improvements in or relating to screening for papilloma viruses
06/11/1998WO1998025142A1 Alarm related peptides and nucleic acids and diagnosis using them
06/11/1998WO1998025125A2 Predisposition to breast cancer by mutations at the ataxia-telangiectasia genetic locus
06/11/1998WO1998024914A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
06/11/1998WO1998024908A1 Human chemokine beta-13
06/11/1998WO1998024906A2 Isolated mammalian monocyte cell genes; related reagents
06/11/1998WO1998024902A1 Adaptor protein frs2 and related products and methods
06/11/1998WO1998024900A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor
06/11/1998WO1998024898A2 Therapeutic composition comprising the kal protein and use of the kal protein
06/11/1998WO1998024897A1 Junctional adhesion molecule (jam), a transmembrane protein of tight junctions
06/11/1998WO1998024894A2 Pkd1 fragments with bonding areas for pkd1-specific antibodies
06/11/1998WO1998024893A2 TRANSGENIC MAMMALS HAVING HUMAN IG LOCI INCLUDING PLURAL VH AND Vλ REGIONS AND ANTIBODIES PRODUCED THEREFROM
06/11/1998WO1998024888A2 Polypeptides encoded by a human lipase-like gene, compositions and methods
06/11/1998WO1998024887A2 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof
06/11/1998WO1998024885A1 Helicobacter pylori antigen having an apparent molecular weight of 16±2 kda, a specific antibody, and its use for the detection of said antigen
06/11/1998WO1998024884A1 Transgenic non-human animals capable of producing heterologous antibodies
06/11/1998WO1998024819A1 5-hydroxytryptophol (5-htol) derivatives, antibodies, immunoassays and detection of recent alcohol consumption
06/11/1998WO1998024818A1 Novel trh receptor
06/11/1998WO1998024817A1 Novel dna, novel protein, and novel antibody
06/11/1998WO1998024810A2 Vertebrate homologues of unc-53 protein of c. elegans
06/11/1998WO1998024808A2 INHIBITION OF IgE-MEDIATED ALLERGIES BY A HUMAN IgE-DERIVED OLIGOPEPTIDE
06/11/1998WO1998012910A3 Novel CREBa isoform
06/11/1998CA2722378A1 Human antibodies that bind tnf alpha
06/11/1998CA2277580A1 Human chemokine beta-13
06/11/1998CA2274316A1 Therapeutic composition comprising the kal protein and use of the kal protein for the treatment of retinal, renal, neuronal and neural injury
06/11/1998CA2274309A1 Novel dna, novel protein, and novel antibody
06/11/1998CA2274305A1 Novel trh receptor
06/11/1998CA2274145A1 Adaptor protein frs2 and related products and methods
06/11/1998CA2274105A1 Transgenic non-human animals capable of producing heterologous antibodies
06/11/1998CA2274011A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
06/11/1998CA2273827A1 Vertebrate homologues of unc-53 protein of c. elegans
06/11/1998CA2273202A1 Junctional adhesion molecule (jam), a transmembrane protein of tight junctions
06/11/1998CA2273198A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor
06/11/1998CA2273184A1 Alarm related peptides and nucleic acids and diagnosis using them
06/11/1998CA2273051A1 Predisposition to breast cancer by mutations at the ataxia-telangiectasia genetic locus
06/11/1998CA2272848A1 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof
06/11/1998CA2224334A1 Self-enhancing, pharmacologically controllable expression systems
06/11/1998CA2224131A1 Novel human 11 cb splice variant
06/10/1998EP0846772A1 Multifunctional ligand system for cell-specific transfer of nucleic acid
06/10/1998EP0846767A2 FtsL - A membrane bound protein from Streptococcus pneumoniae
06/10/1998EP0846766A2 IgA Fc binding protein from Streptococcus pneumoniae
06/10/1998EP0846764A2 Glial cell line-derived neurotrophic factor alpha receptor family
06/10/1998EP0846763A2 A protein phosphatase 1 binding protein, R5
06/10/1998EP0846762A2 Novel V31 seven transmembrane receptors
06/10/1998EP0846761A1 A novel transcription factor expressed in cycling cells, nucleic acid molecules encoding said transcription factor and its promoter region and uses thereof
06/10/1998EP0846760A1 Production and use of anthelmintic agents and protective immunogens
06/10/1998EP0846700A1 Pollen Allergens
06/10/1998EP0846266A1 Differential assay for ulcerative colitis, primary sclerosing cholangitis and type 1 autoimmune hepatitis
06/10/1998EP0846183A2 High efficiency retroviral packaging system
06/10/1998EP0846178A1 Allergen-xcd32 fusion proteins
06/10/1998EP0846173A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/10/1998EP0846169A1 MONOCLONAL ANTIBODIES AGAINST SOLUBLE TNF-ALPHA RECEPTORS p55 and p75 AS WELL AS AGAINST TNF-ALPHA AND ITS ANALOGUES
06/10/1998EP0846165A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof